Reducing Reintubation Risk in High-Risk Cardiac Surgery Patients With High-Flow Nasal Cannula | MicrobiomeTrials← Back to trialsNCT04782817
Reducing Reintubation Risk in High-Risk Cardiac Surgery Patients With High-Flow Nasal Cannula
CompletedNAINTERVENTIONAL
Trial Details
Start: 2021-11-01Est. Completion: 2025-11-19
Enrollment target: 3,568 participants Locations- Vanderbilt University Medical Center, Nashville, Tennessee, United States
Other microbiome trials you might be interested in
CABGGraft FailureColchicine
This is a single-center, prospective, randomized, open-label, assessor-blinded, blank-controlled exploratory (pilot) tri…
Shanghai, ChinaEst. completion Oct 2027
Neonatal Respiratory Distress Syndrome
Newborn babies who have difficulty breathing may need breathing support to help them receive enough oxygen. Two commonly…
Islamabad, PakistanCompleted Sep 20, 2025